Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 9/2003

01-09-2003 | Case report

Octreotide in control of multiple liver metastases from gastrinoma

Authors: Fumito Saijo, Hiroo Naito, Yuji Funayama, Kouhei Fukushima, Chikashi Shibata, Akihiko Hashimoto, Taku Kitayama, Munenori Nagao, Seiki Matsuno, Iwao Sasaki

Published in: Journal of Gastroenterology | Issue 9/2003

Login to get access
Metadata
Title
Octreotide in control of multiple liver metastases from gastrinoma
Authors
Fumito Saijo
Hiroo Naito
Yuji Funayama
Kouhei Fukushima
Chikashi Shibata
Akihiko Hashimoto
Taku Kitayama
Munenori Nagao
Seiki Matsuno
Iwao Sasaki
Publication date
01-09-2003
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 9/2003
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-002-1170-8

Other articles of this Issue 9/2003

Journal of Gastroenterology 9/2003 Go to the issue

Editorial

Is the incidence of intrahepatic multicentric recurrence of hepatocellular carcinoma more frequent in “the carcinogenic stage” than in liver cirrhosis?

Review

Folic acid, polymorphism of methyl-group metabolism genes, and DNA methylation in relation to GI carcinogenesis

OriginalPaper

Elevated expression of caveolin-1 at protein and mRNA level in human cirrhotic liver: relation with nitric oxide

OriginalPaper

Hypertonic saline-epinephrine injection plus endoscopic band ligation therapy for gastric Dieulafoy’s lesion

OriginalPaper

Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis

OriginalPaper

Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits